RECORDATI RARE DISEASES, INC. drugs
6 results
Cystadrops (cysteamine hydrochloride)
(cysteamine hydrochloride)RECORDATI RARE DISEASES, INC.
Usage: CYSTADROPS is indicated for treating corneal cystine crystal deposits in adults and children diagnosed with cystinosis, acting as a cystine-depleting agent.
Enjaymo (sutimlimab-jome)
(sutimlimab-jome)Recordati Rare Diseases, Inc.
Usage: ENJAYMO (sutimlimab-jome) is indicated for the treatment of hemolysis in adults with cold agglutinin disease (CAD).
Isturisa (osilodrostat)
(Osilodrostat)Recordati Rare Diseases, Inc.
Usage: ISTURISA is indicated for treating endogenous hypercortisolemia in adults with Cushing's syndrome when surgery is not an option or has not resolved the condition.
Panhematin (hemin)
(hemin)Recordati Rare Diseases, Inc.
Usage: PANHEMATIN is indicated for alleviating recurrent attacks of acute intermittent porphyria related to the menstrual cycle in women, following inadequate initial carbohydrate therapy. It is not effective in repairing neuronal damage but aims to prevent attacks from progressing to critical stages.
Signifor (pasireotide)
(pasireotide)Recordati Rare Diseases, Inc.
Usage: SIGNIFOR is indicated for treating adult patients with Cushing's disease when pituitary surgery is not feasible or has not resulted in a cure.
Signifor lar (pasireotide)
(pasireotide)Recordati Rare Diseases, Inc.
Usage: SIGNIFOR LAR is indicated for treating acromegaly in patients unresponsive to surgery or for whom surgery is not viable. Additionally, it is used for patients with Cushing's disease when pituitary surgery is not an option or has failed to cure the condition.